Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

Two weeks ago, a blogger wrote about a Yale School of Medicine study that he alleged proved that millions of long COVID sufferers might, in fact, have been injured by the vaccine. The story blew up on ...

The key player in SARS-CoV-2's infection process is the receptor binding domain (RBD) of the spike protein. The RBD determines how well the virus binds to ACE2, the human cellular receptor ...

Swipe to advance through slides First, It Binds to a Lung Cell When a virus spike protein latches onto an ACE2 receptor, a protease enzyme slices off the spike's head. (ACE2 normally helps ...

"The 'key' is the viral spike protein and the 'lock' is the cell's ACE2 receptor. The 'teeth' on the key are the spike amino ...

The spike protein of the new coronavirus infected human cells that had high levels of the ACE2 receptor in test tubes, as well as in small models of human airways and intestines. The researchers ...

Get Instant Summarized Text (Gist) CeSPIACE is a peptide inhibitor designed to block the interaction between the SARS-CoV-2 spike protein and ACE2 receptors, preventing infection. It remains ...